article · Asian Pacific Journal of Cancer Prevention
The abstract on record is too brief for a reliable plain-language summary, so none has been generated.
The addition of metformin to standard R-CHOP could improve clinical outcomes in patients with DLBCL with a tolerable safety profile.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.31557/apjcp.2024.25.7.2351
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
